CRSP

CRISPR Therapeutics AG NGM · CRSP

$48.15 +1.16 (+2.47%)

Pullback · -1.45σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $4.7B

P/E (ttm) —

Forward P/E -12.4

Beta (5y) 1.70

Shares out 98.5M

Div yield —

Profitability & returns

ROE -31.2%

Net margin —

FCF margin -6358.7%

Debt / equity 0.43

Trading information

Last price $48.15

Day range $46.86 – $48.62

52-wk range $44.12 – $63.45

Avg volume 1.8M

RSI (2) 54.2

Trend zone Pullback

52-week range · today's price

$44.12$63.45

Company

Sector Healthcare

Industry Biotechnology

Exchange NGM

Next earnings 2026-05-11

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs …